The Billion-Dollar Molecule The Billion-Dollar Molecule

The Billion-Dollar Molecule

The Quest for the Perfect Drug

    • 3.9 • 13 Ratings
    • $14.99
    • $14.99

Publisher Description

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.

Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.

You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

GENRE
Business & Personal Finance
RELEASED
2013
August 20
LANGUAGE
EN
English
LENGTH
464
Pages
PUBLISHER
Simon & Schuster
SELLER
Simon & Schuster Digital Sales LLC
SIZE
3.3
MB

More Books Like This

Loonshots Loonshots
2019
The Age of Heretics The Age of Heretics
2008
Good Guys and Bad Guys Good Guys and Bad Guys
2008
Clutch Clutch
2010
The Man Who Solved the Market The Man Who Solved the Market
2019
The New New Thing: A Silicon Valley Story The New New Thing: A Silicon Valley Story
1999

More Books by Barry Werth

The Antidote The Antidote
2014
31 Days 31 Days
2006
Banquet at Delmonico's Banquet at Delmonico's
2009
The Scarlet Professor The Scarlet Professor
2001
Damages Damages
2013
Prisoner of Lies Prisoner of Lies
2024

Customers Also Bought

Genentech Genentech
2011
For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug
2023
The Fund The Fund
2023
The Innovator's Dilemma The Innovator's Dilemma
2015
The Gene The Gene
2016
The Man Who Solved the Market The Man Who Solved the Market
2019